Clinical Trial Update: Clinical Trial of PXD101 in Patients With Advanced Multiple Myeloma [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 clinical trial evaluating belinostat (PXD101) in patients with advanced multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Belinostat (belinostat)

Snippet

Sponsor: Valerio Therapeutics | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED